Professors Rik Bryan and Nicholas James explain how an image-directed pathway for muscle-invasive bladder cancer improves ...

Updated results from the NIAGARA trial further support perioperative durvalumab and neoadjuvant chemotherapy as a potential new treatment for patients with muscle-invasive bladder cancer, according to ...

An expert discusses how medical professionals monitor and manage adverse events (AEs) with adjuvant nivolumab through regular ...

An expert discusses how medical professionals counsel eligible patients about adjuvant immune checkpoint inhibitor (ICI) ...

Discover how AI-based assays offer a promising approach to tailor treatment for high-risk non-muscle-invasive bladder cancer.

编者按： ...

Net research and development expenses for the device division increased in 2024 to CAD175,000 from CAD44,000 in 2023, a 400% increase. The increase is attributed to development of a new software ...

Association of intensifying supportive care with improved survival in patients with gastric cancer with malignant ascites.

"The results [indicate] that neoadjuvant DV combined with toripalimab had promising efficacy and acceptable safety in patients with HER2-expressing MIBC,” said Xinan Sheng, MD. The pCR was 37.3% (95% ...

In 2025, Australian women are still suffering in silence. It's a confronting reality: 82 per cent of women feel they are the ...

Kista ovarium menjadi salah satu momok yang ditakuti perempuan. Padahal, dengan deteksi dini dan perawatan, kista ini bisa disembuhkan.